Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Majowicz

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Human Gene Therapy|January 22, 2024
Complement System Response to Adeno-Associated Virus Vector Gene TherapyElizabeth Kropf, David M Markusic, Anna Majowicz, et al.
World Journal of Gastrointestinal Pathophysiology|December 20, 2011
Gene and cell therapy based treatment strategies for inflammatory bowel diseasesSander van der Marel, Anna Majowicz, Sander van Deventer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2017
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5<sup>ch</sup> and AAV1Anna Majowicz, David Salas, Nerea Zabaleta, et al.
BMC Gastroenterology|December 4, 2012
Murine CD4⁺CD25⁻ cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivoAnna Majowicz, Sander van der Marel, Anje A te Velde, et al.
Molecular Therapy. Methods & Clinical Development|July 6, 2019
Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABsAnna Majowicz, Bart Nijmeijer, Margit H Lampen, et al.
The Journal of Gene Medicine|May 10, 2013
Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene deliveryAnna Majowicz, Piotr Maczuga, Karin L Kwikkers, et al.
Frontiers in Immunology|May 8, 2026
Intravitreal AAV vector delivery induces integrin-dependent ocular inflammation, complement activation, and antiviral and DNA damage responsesHelena Costa-Verdera, Deepa Jamwal, Emily Fabyanic, et al.
Frontiers in Immunology|October 3, 2022
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human bloodCorinne J Smith, Nikki Ross, Ali Kamal, et al.
World Journal of Gastroenterology|September 13, 2012
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitisSander van der Marel, Anna Majowicz, Karin Kwikkers, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Human Gene Therapy|January 22, 2024
Complement System Response to Adeno-Associated Virus Vector Gene TherapyElizabeth Kropf, David M Markusic, Anna Majowicz, et al.
World Journal of Gastrointestinal Pathophysiology|December 20, 2011
Gene and cell therapy based treatment strategies for inflammatory bowel diseasesSander van der Marel, Anna Majowicz, Sander van Deventer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 10, 2017
Successful Repeated Hepatic Gene Delivery in Mice and Non-human Primates Achieved by Sequential Administration of AAV5<sup>ch</sup> and AAV1Anna Majowicz, David Salas, Nerea Zabaleta, et al.
BMC Gastroenterology|December 4, 2012
Murine CD4⁺CD25⁻ cells activated in vitro with PMA/ionomycin and anti-CD3 acquire regulatory function and ameliorate experimental colitis in vivoAnna Majowicz, Sander van der Marel, Anje A te Velde, et al.
Molecular Therapy. Methods & Clinical Development|July 6, 2019
Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABsAnna Majowicz, Bart Nijmeijer, Margit H Lampen, et al.
The Journal of Gene Medicine|May 10, 2013
Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene deliveryAnna Majowicz, Piotr Maczuga, Karin L Kwikkers, et al.
Frontiers in Immunology|May 8, 2026
Intravitreal AAV vector delivery induces integrin-dependent ocular inflammation, complement activation, and antiviral and DNA damage responsesHelena Costa-Verdera, Deepa Jamwal, Emily Fabyanic, et al.
Frontiers in Immunology|October 3, 2022
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human bloodCorinne J Smith, Nikki Ross, Ali Kamal, et al.
World Journal of Gastroenterology|September 13, 2012
Adeno-associated virus mediated delivery of Tregitope 167 ameliorates experimental colitisSander van der Marel, Anna Majowicz, Karin Kwikkers, et al.
Pageof 1